To our knowledge, this is the first study demonstrating DNMT3A silencing of LncRNA ANRIL regulates HSC activation, thus providing novel mechanistic insights into a critical role for LncRNA ANRIL in liver fibrosis pathogenesis. This evidence concerns the gene CDKN2B-AS1 and Hepatic fibrosis.